Acquisition Momentum Metrics, Inc. has recently changed ownership and expanded capacity in North Carolina, signaling ongoing integration opportunities with parent entities and potential cross-sell of development, analytical testing, and commercial manufacturing services to Catalent and Mayne Pharma portfolios.

End-to-End CDMO Position as a single-site, concept-to-commercialization partner for novel oral dosage forms to reduce client transfer risk and accelerate time-to-market, presenting opportunities to win full-CDMO engagements from sponsors seeking streamlined supply chains.

Strong Client Loyalty With over 95 percent of clients indicating intent to work again, emphasize upsell and expanded service lines such as scale-up analytics, regulatory support, and post-approval manufacturing for existing relationships in North America and globally.

OSD Expertise Target organic growth in the novel oral solid dose segment by leveraging proficiency in development, analytical testing, and commercial manufacturing to pursue new chemical entities or complex dosage forms from mid-market pharma companies and biotech clients.

Capability Fit Highlight the Greenville, NC campus as a strategic expansion hub with scalable manufacturing and integrated project management, offering bundled services to clients facing transfer risk or capacity constraints at multi-site CDMOs.